美国生物技术公司Establishment Labs Holdings Inc.（股票代码：ESTA）周四盘前股价大跌8.35%，主要受到公司第二季度财报的影响。尽管公司营收增长强劲，但亏损扩大超出市场预期，引发投资者担忧。
根据公司发布的财报，Establishment Labs第二季度营收为5130万美元，同比增长16.3%，略高于分析师预期的5100万美元。然而，公司净亏损扩大至1659万美元，每股亏损0.57美元，均未达到分析师预期。特别值得注意的是，公司运营亏损达1410.7万美元，远超IBES预期的1060万美元，这可能是导致股价下跌的主要原因。
尽管业绩表现不佳，但Establishment Labs仍然对未来保持乐观。公司将2025年全年营收指引上调至2.08亿-2.12亿美元，反映出美国市场销售势头强劲。公司Motiva产品在美国的销售为第二季度贡献了1030万美元的营收。此外，公司预计2025年将实现正EBITDA，并在2026年实现现金流转正。然而，这些积极的展望似乎未能抵消投资者对当前亏损扩大的担忧，导致股价大幅下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.